Cross-subtype T-cell immune responses induced by a human immunodeficiency virus type 1 group m consensus env...

Area of Science:

• Immunology
• Virology
• Vaccine Development

Background:

• Global human immunodeficiency virus type 1 (HIV-1) genetic diversity poses a significant hurdle for vaccine design.
• Developing an HIV-1 vaccine that elicits cross-subtype immune responses is crucial for global efficacy.

Purpose of the Study:

• To compare T-cell responses induced by a synthetic consensus env gene (CON6) versus natural subtype env immunogens.
• To evaluate the potential of CON6 as a strategy for broad HIV-1 vaccine design.

Main Methods:

• Mice were immunized using a DNA prime-recombinant vaccinia virus boost strategy with CON6 or subtype A, B, or C env immunogens.
• T-cell epitopes were mapped using gamma interferon enzyme-linked immunospot (ELISPOT) assays with overlapping Env peptides.
• Responses were analyzed across different mouse strains and Env subtypes.

Main Results:

• The CON6 vaccine was immunogenic, inducing a higher number of T-cell epitope responses compared to individual wild-type subtype immunogens.
• CON6 elicited T-cell responses comparable to a polyvalent vaccine and superior to responses against between-clade subtypes.
• The magnitude of T-cell responses to CON6 was greater than to individual wild-type env immunogens.

Conclusions:

• Synthetic consensus env immunogens, like CON6, represent a promising strategy for HIV-1 vaccine development.
• These findings suggest CON6 can induce broader and more potent T-cell responses, meriting further investigation in non-human primates and humans.